跳至主要内容
临床试验/CTRI/2018/02/012232
CTRI/2018/02/012232已完成未知

Effect of antiepileptic drugs on bone in women: role of Wnt pathway

Department of Science and Technology0 个研究点目标入组 66 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients receiving sodium valproate, carbamazepine or levetiracetam as monotherapy for atleast a year.

排除标准

  • Women with conditions known to affect bone and mineral metabolism (such as primary hyperparathyroidism, Pagetâ??s disease, multiple myeloma, hepatic or renal disorders, diabetes mellitus, thyroid diseases, malignancy or malabsorption)
  • Women taking glucocorticoids that are known to affect bone and mineral metabolism.
  • Patients in which sodium valproate, carbamazepine and levetiracetam are prescribed for condition other than epilepsy.
  • Patients with smoking habit.
  • Patients who refuse to give consent.

研究者

相似试验